Health

Companies engaged in biotechnology, pharmaceuticals, research services, home healthcare, hospital operations, long‑term care, and the manufacture and supply of medical equipment and supplies. The sector also includes pharmaceutical retailers and providers of health‑information services. UK‑listed companies in this sector include AstraZeneca plc, GlaxoSmithKline plc, Smith & Nephew plc, Hikma Pharmaceuticals plc, ConvaTec Group plc, Spire Healthcare plc and EMIS Group plc.

Cizzle Biotechnology targets early lung cancer detection market

Cizzle Biotechnology is targeting the early lung cancer detection market with a blood-based test aimed at addressing a major unmet medical need...

May 20, 2026

EDX Medical targets AIM growth with ultra-accurate cancer diagnostics

EDX Medical Chief Scientific Officer Professor Chris Evans discusses the company’s AIM admission, prostate cancer testing programme in Scotland, and plans to commercialise a range of advanced diagnostic tests...

May 20, 2026

Pet healthspan focus opens a clearer senior care opportunity

Senior pet wellness is gaining relevance as owners focus on helping dogs and cats live better, not just longer...

May 20, 2026

Verici Dx publishes clinical validation study for PTRA kidney transplant test

Verici Dx says a clinical validation study published in Kidney360 found its PTRA test outperformed conventional tools in predicting early acute rejection after kidney transplant...

May 19, 2026

Japan expands approval of GSK’s Arexvy to at-risk adults aged 18–49

GSK says Japan has expanded Arexvy eligibility to adults aged 18–49 at increased risk of RSV disease, including immunocompromised patients...

May 18, 2026

AstraZeneca and Daiichi Sankyo secure FDA approval for Enhertu in early breast cancer

The FDA has approved AstraZeneca and Daiichi Sankyo’s Enhertu for both neoadjuvant and adjuvant treatment of HER2-positive early breast cancer, based on results from the Phase III DESTINY-Breast11 and DESTINY-Breast05..

May 18, 2026

Kidney transplant sector faces push for new therapies and system reform

Transplant specialist Roslyn Mannon says new therapies, organ preservation technologies and transplant system reform are set to reshape kidney transplantation...

May 15, 2026

Healthspan moves up the investor agenda

Healthspan is becoming a clearer investor theme as ageing markets shift towards prevention, function and healthier later-life years...

May 14, 2026

Spire Healthcare confirms FY26 outlook after in-line trading

Spire Healthcare said trading for the first four months of 2026 was in line with expectations, with strong private patient revenue growth and FY26 adjusted EBITDA still targeted broadly in..

May 14, 2026

EDX Medical begins trading on AIM following move from Aquis

EDX Medical has commenced trading on the AIM market of the London Stock Exchange under the ticker EDX, highlighting its growth strategy in cancer and infectious disease diagnostics and its..

May 13, 2026

Genflow adds delivery expertise through fully funded Acuitas deal

Genflow Biosciences has secured a fully funded delivery collaboration with Acuitas Therapeutics, giving investors a clearer view of how the company plans to advance its SIRT6 gene therapy platform...

May 12, 2026

GSK partners with SBP Group to support bepirovirsen launch in China

GSK has entered an exclusive collaboration with SBP Group’s CTTQ unit to accelerate the launch of bepirovirsen, a potential first-in-class chronic hepatitis B treatment currently under priority review in China...

May 11, 2026

IP Group’s New Chair Designate Signals Confidence in Long Term Growth, Equity Development

IP Group appoints former 3i CEO Michael Queen as Chair Designate as Equity Development highlights significant NAV discount potential...

May 7, 2026

Ethtry invests £500k in Cerulean Winds offshore wind loan

Ethtry Plc commits £500,000 to a senior secured facility supporting Cerulean Winds’ floating offshore wind project, expanding its strategy beyond Ethereum treasury holdings into energy transition investments...

May 6, 2026

Smith & Nephew reports steady Q1 growth and confirms 2026 outlook

Underlying revenue grew 3.1% in Q1, supported by innovation and strong Sports Medicine performance. The company maintains its full-year targets and unveils a new $500m buyback program...

May 6, 2026

Cizzle Biotechnology to issue shares following £400,000 CLN conversion

Cizzle Biotechnology will issue 28,571,429 new ordinary shares after receiving a conversion notice for £400,000 of convertible loan notes held by Frazer Lang...

May 6, 2026

Atlantic AI Summit adds AI ethics and healthcare innovation keynote

The 2026 Atlantic AI Summit has named Dr Michael M Karch as a keynote speaker, with a focus on AI readiness, ethics, and leadership...

May 1, 2026

Genflow Biosciences delivers strong 2025 progress across key programs

Genflow Biosciences’ 2025 results highlight strong operational progress, including a major milestone in its dog aging study, advancement of its MASH program toward clinical readiness, expanded global patent protection, and..

May 1, 2026

Cizzle Biotechnology 2025 results highlight licensing and clinical progress

Cizzle Biotechnology has released its Annual Report for the year ended 31 December 2025, outlining progress toward commercialising its early lung cancer blood test and detailing financial results, partnerships, and..

April 30, 2026

Verici Dx shows stronger signs of commercial adoption

Verici Dx is building commercial momentum as Tutivia gains repeat use across US kidney transplant centres...

April 28, 2026

News and Interview Alerts

Company Presentations

Norcros Plc CEO and CFO Present Interim Results to 30 September 2024 (LON:NXR)

Ilika plc: A New Era in Solid-State Battery Innovation – 2024 Investor Presentation

Time Finance PLC Strong Growth and Strategic Progress: A Message from CEO Ed Rimmer

SAE Renewables Future Strategy to 2035 and Investment Case by Graham Reid CEO

Q&As

Firering Strategic Minerals’ Vassilios Carellas discusses Limeco growth plans

4 June 2026

DynaResource CEO Rohan Hazelton outlines Q1 growth and 2026 exploration plans

4 June 2026

Douglas Grant, Manx Financial CEO, on 2025 results, deposit growth and 2026 outlook

4 June 2026

EDX Medical targets AIM growth with ultra-accurate cancer diagnostics

20 May 2026

Likewise CEO Tony Brewer on supply chain, growth and logistics investment

20 May 2026

Hardman & Co

Cavendish plc: Solid performance in still tough markets

30 June 2026

Cavendish plc delivers solid performance in tough markets

24 June 2026

ICG Enterprise Trust FY’26 results: look to future realisations

11 June 2026

NB Private Equity Partners 2025 results: Looking to future realisations

29 May 2026

Chesnara Plc: Showing good operational progress

17 April 2026

Green News

Quadrise plc launches proposed fundraise to support commercial trials and growth

8 July 2026

Ilika raises £4.56m in oversubscribed placing and subscription

3 July 2026

Ilika launches Retail Offer to raise up to £0.5 Million

3 July 2026

Net Zero Infrastructure appoints Clear Capital Markets as broker

1 July 2026

View all Sustainable sectors, Plcs and news >>

Search

Latest Interviews

Firering Strategic Minerals: LimeCo Stake Rises as Kilns 3 and 4 Set Up the Next Growth Test (video)

DynaResource: Higher Revenues, New Veins And A 2026 Push To Unlock San José de Gracia’s Bigger Prize (video)

Manx Financial Group Expands Lending Push with Deposits Up 12% and New Products Incoming (video)

EDX Medical Group: Sir Chris Evans on the Diagnostics Shift That Could Redefine Early Cancer Detection (video)

Chesnara: Why Two Deals Are Reshaping Cash Generation and Dividend Confidence (video)

BrokerTalk

Capricorn Energy Strengthens Momentum Ahead of Egypt Concession Catalyst, Cavendish

28 May 2026

Biotech Growth Trust: A focused route into a biotech recovery

26 May 2026

Hercules Plc reports robust FY25 growth, says latest SP Angel research note

25 May 2026

Sintana Energy enters a high-impact drilling phase, Auctus Advisors

21 May 2026

Finseta fundraising supports European growth plans, says Shore Capital

20 May 2026

Funds

Gold’s changing market role reshapes portfolio positioning | Ruffer Investment Company

10 July 2026

Biotech Growth Trust: The biotech rebound powered by innovation, valuations and pharma’s patent cliff

8 July 2026

TEAM plc completes acquisition of EPIC Book

1 July 2026

Geiger Counter reports 21.6% NAV increase in interim results

30 June 2026

Fidelity China Special Situations outperforms amid China’s tech revival (LON: FCSS)

30 June 2026

View all Funds, Market Insights and news >>

FTSE 100 News

Smiths Group completes Smiths Detection sale and outlines shareholder return plan

1 July 2026

Segro Plc rejects Prologis proposal and outlines value case

30 June 2026

Vodafone confirms completion of Safaricom stake acquisition

30 June 2026

SSE’s SSEN Transmission welcomes NESO’s Beyond 2030 Update

30 June 2026

UK Broker Ratings

FirstGroup PLC (FGP.L) Stock Report: Exploring a 40.91% Potential Upside and Robust Dividends

7 July 2026

Goodwin PLC ORD 10P (GDWN.L) Stock Analysis: Strong Revenue Growth Amidst Uncertain Valuation

7 July 2026

Chemring Group PLC (CHG.L) Stock Analysis: Aerospace & Defense Leader with 10.22% Potential Upside

7 July 2026

Alfa Financial Software Holdings (ALFA.L) Stock Analysis: A 66.34% Upside Potential Beckons Investors

7 July 2026

Hilton Food Group (HFG.L) Stock Analysis: Exploring a 27.59% Upside Potential for Investors

7 July 2026

Health

Cizzle Biotechnology targets early lung cancer detection market

Cizzle Biotechnology is targeting the early lung cancer detection market with a blood-based test aimed at addressing a major unmet medical need...

May 20, 2026

EDX Medical targets AIM growth with ultra-accurate cancer diagnostics

May 20, 2026

Pet healthspan focus opens a clearer senior care opportunity

Senior pet wellness is gaining relevance as owners focus on helping dogs and cats live better, not just longer...

May 20, 2026

Verici Dx publishes clinical validation study for PTRA kidney transplant test

Verici Dx says a clinical validation study published in Kidney360 found its PTRA test outperformed conventional tools in predicting early acute rejection after kidney transplant...

May 19, 2026

Japan expands approval of GSK’s Arexvy to at-risk adults aged 18–49

GSK says Japan has expanded Arexvy eligibility to adults aged 18–49 at increased risk of RSV disease, including immunocompromised patients...

May 18, 2026

AstraZeneca and Daiichi Sankyo secure FDA approval for Enhertu in early breast cancer

May 18, 2026

Kidney transplant sector faces push for new therapies and system reform

Transplant specialist Roslyn Mannon says new therapies, organ preservation technologies and transplant system reform are set to reshape kidney transplantation...

May 15, 2026

Healthspan moves up the investor agenda

Healthspan is becoming a clearer investor theme as ageing markets shift towards prevention, function and healthier later-life years...

May 14, 2026

Spire Healthcare confirms FY26 outlook after in-line trading

Spire Healthcare said trading for the first four months of 2026 was in line with expectations, with strong private patient revenue growth and FY26 adjusted EBITDA still targeted broadly in line with FY25...

May 14, 2026

EDX Medical begins trading on AIM following move from Aquis

EDX Medical has commenced trading on the AIM market of the London Stock Exchange under the ticker EDX, highlighting its growth strategy in cancer and infectious disease diagnostics and its expanding portfolio of personalised healthcare technologies...

May 13, 2026

Genflow adds delivery expertise through fully funded Acuitas deal

Genflow Biosciences has secured a fully funded delivery collaboration with Acuitas Therapeutics, giving investors a clearer view of how the company plans to advance its SIRT6 gene therapy platform...

May 12, 2026

GSK partners with SBP Group to support bepirovirsen launch in China

May 11, 2026

IP Group’s New Chair Designate Signals Confidence in Long Term Growth, Equity Development

IP Group appoints former 3i CEO Michael Queen as Chair Designate as Equity Development highlights significant NAV discount potential...

May 7, 2026

Ethtry invests £500k in Cerulean Winds offshore wind loan

May 6, 2026

Smith & Nephew reports steady Q1 growth and confirms 2026 outlook

Underlying revenue grew 3.1% in Q1, supported by innovation and strong Sports Medicine performance. The company maintains its full-year targets and unveils a new $500m buyback program...

May 6, 2026

Cizzle Biotechnology to issue shares following £400,000 CLN conversion

Cizzle Biotechnology will issue 28,571,429 new ordinary shares after receiving a conversion notice for £400,000 of convertible loan notes held by Frazer Lang...